ES2156605T3 - Procedimiento de preparacion de un 3,5-hidrato de dihidrocloruro de 3-(2-(4-(3-cloro-2-metilfenil)-1-piperazinil)etil)-5,6-dimetoxi-1-(4-imidazolilmetil)-1h-indazol. - Google Patents

Procedimiento de preparacion de un 3,5-hidrato de dihidrocloruro de 3-(2-(4-(3-cloro-2-metilfenil)-1-piperazinil)etil)-5,6-dimetoxi-1-(4-imidazolilmetil)-1h-indazol.

Info

Publication number
ES2156605T3
ES2156605T3 ES95936786T ES95936786T ES2156605T3 ES 2156605 T3 ES2156605 T3 ES 2156605T3 ES 95936786 T ES95936786 T ES 95936786T ES 95936786 T ES95936786 T ES 95936786T ES 2156605 T3 ES2156605 T3 ES 2156605T3
Authority
ES
Spain
Prior art keywords
methylphenyl
chloro
imidazolilmetil
hydrochlate
dimetoxi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95936786T
Other languages
English (en)
Inventor
Kenjiro Yamamoto
Akihiko Miyadera
Hiroaki Kitaoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2156605T3 publication Critical patent/ES2156605T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

CRISTALES DE DIHIDROCLORURO DE 3-[[]2-[[]4-(()3-CLORO-2METILFENIL())-1-PIPERAZINIL[]]ETIL[]]-5,6-DIMETOXI-1-(()4IMIDAZOLILMETIL())-1H-INDAZOL EL CUAL ES UN HIDRATO PARA USO FARMACEUTICO QUE TIENE EXCELENTES CARACTERISTICAS COMO UN MATERIAL FARMACEUTICO QUE TIENE ALTA ESTABILIDAD EN ALMACENAMIENTO Y EL CUAL TIENE CARACTERISTICAS DE DIFRACCION DE RAYOS X SUSTANCIALMENTE ESPECIFICADAS, EN CONCRETO, EL DIHIDROCLORURO ES 3,5-HIDRATO.
ES95936786T 1994-11-14 1995-11-14 Procedimiento de preparacion de un 3,5-hidrato de dihidrocloruro de 3-(2-(4-(3-cloro-2-metilfenil)-1-piperazinil)etil)-5,6-dimetoxi-1-(4-imidazolilmetil)-1h-indazol. Expired - Lifetime ES2156605T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27820494 1994-11-14

Publications (1)

Publication Number Publication Date
ES2156605T3 true ES2156605T3 (es) 2001-07-01

Family

ID=17594052

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95936786T Expired - Lifetime ES2156605T3 (es) 1994-11-14 1995-11-14 Procedimiento de preparacion de un 3,5-hidrato de dihidrocloruro de 3-(2-(4-(3-cloro-2-metilfenil)-1-piperazinil)etil)-5,6-dimetoxi-1-(4-imidazolilmetil)-1h-indazol.

Country Status (16)

Country Link
US (1) US5948913A (es)
EP (1) EP0792879B1 (es)
KR (1) KR100372188B1 (es)
CN (1) CN1067998C (es)
AT (1) ATE199375T1 (es)
AU (1) AU698464B2 (es)
CA (1) CA2205206A1 (es)
DE (1) DE69520225T2 (es)
DK (1) DK0792879T3 (es)
ES (1) ES2156605T3 (es)
FI (1) FI972035A (es)
GR (1) GR3035820T3 (es)
NO (1) NO972190L (es)
PT (1) PT792879E (es)
RU (1) RU2152941C1 (es)
WO (1) WO1996015124A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE510650C2 (sv) 1997-05-30 1999-06-14 Astra Ab Ny förening
CA2309350C (en) 1997-11-12 2007-04-03 Mitsubishi Chemical Corporation Purine derivatives and medicaments comprising the same as active ingredient
AU4319000A (en) * 1999-05-11 2000-11-21 Mitsubishi Chemical Corporation Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines
AU672047B2 (en) * 1992-10-06 1996-09-19 Ciba-Geigy Ag Novel thiosemicarbazonethiones
RU2124511C1 (ru) * 1993-05-14 1999-01-10 Фармасьютикал Ко., Лтд Производные пиперазина
US5681954A (en) * 1993-05-14 1997-10-28 Daiichi Pharmaceutical Co., Ltd. Piperazine derivatives
JPH0741431A (ja) * 1993-05-25 1995-02-10 Dai Ichi Seiyaku Co Ltd 脳保護薬
NO941915L (no) * 1993-05-25 1994-11-28 Daiichi Seiyaku Co Madikament for nervebeskyttelse

Also Published As

Publication number Publication date
AU698464B2 (en) 1998-10-29
CA2205206A1 (en) 1996-05-23
KR100372188B1 (ko) 2003-05-12
DK0792879T3 (da) 2001-03-26
DE69520225T2 (de) 2001-10-11
DE69520225D1 (de) 2001-04-05
GR3035820T3 (en) 2001-07-31
WO1996015124A1 (fr) 1996-05-23
ATE199375T1 (de) 2001-03-15
RU2152941C1 (ru) 2000-07-20
NO972190D0 (no) 1997-05-13
AU3856595A (en) 1996-06-06
NO972190L (no) 1997-07-14
EP0792879B1 (en) 2001-02-28
EP0792879A4 (en) 1998-02-25
EP0792879A1 (en) 1997-09-03
US5948913A (en) 1999-09-07
FI972035A0 (fi) 1997-05-13
CN1067998C (zh) 2001-07-04
PT792879E (pt) 2001-08-30
KR970707118A (ko) 1997-12-01
CN1171786A (zh) 1998-01-28
FI972035A (fi) 1997-07-11

Similar Documents

Publication Publication Date Title
FI933804A0 (fi) Monohydrat av 5-(2-(4-(1,2-bensisotiazol-3-yl)-1-piperazinyl)etyl-6-klor-1,3-dihydro-2h-indol-2-onkhydroklorid
DK0590428T3 (da) Azaquinoxaliner, fremgangsmåde til deres fremstilling og deres anvendelse
AU2178895A (en) Heterocyclic-cyclic amine derivatives
MY128664A (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
NO921835L (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
FI935360A0 (fi) Guanidinalkyl-1,1-bifosfonsyraderivat, foerfarande foer deras framstaellning samt deras anvaendning
MY119997A (en) Mesylate dihydrate salts of 5-(2-(4-(1, 2-benzisothiazol-3-yl) -1-piperazinyl)-6-chloro-1, 3- dihydro-2h-indol-2-one
IL89369A (en) Substituted 2-(heterocyclylphenyl)- 1,2,4-triazine-3,5- diones, their preparation and their use
MA21781A1 (fr) Esters ((1,3,5,-triazine-2-yl) aminocarboxyl)-aminosulfonyl) benzoiques herbicides, procedes pour leur preparation et leur utilisation .
ES2156605T3 (es) Procedimiento de preparacion de un 3,5-hidrato de dihidrocloruro de 3-(2-(4-(3-cloro-2-metilfenil)-1-piperazinil)etil)-5,6-dimetoxi-1-(4-imidazolilmetil)-1h-indazol.
GR3005254T3 (es)
AU545216B2 (en) 2-(4-benzylpiperidino)-1-(4 halo-phenyl)piopan-1-ol
ATE63309T1 (de) 2,3-dihydro-2-oxo-3-benzofuranylessigs|urederivate und diese enthaltende arzneimittel.
NO172339C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv (+)1-((3,4,5-trimetoksy)benzyloksymetyl)-1-fenyl-n,n-dimetyl-n-propylamin
ES2058174T3 (es) 10-cianometilenpirrolo(4,3-e)-benzo-azepinas 4-substituidas.
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
MY109504A (en) Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-yl)-1- piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2- one hydrochloride
AR242791A1 (es) Nuevos compuestos derivados de las 2-(6 fluoruro-3h-benzotiazolon-5-ilo-4,5,6,7-tetrahidro-2h-isoindol-1,3-dionas, utiles como herbicidas, procedimiento para obtenerlos.
MX6462E (es) Procedimiento para preparar 2-(3-(4-(3-cloro-4-fluorofenil)-1-piperazinil)propil)-1,2,4-triazolo(4-3-a)piridin-3-(2h)-ona
IT1191617B (it) Propionilanilidi farmacologicamente attive

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 792879

Country of ref document: ES